Skip to content

Variations of Cognitive Behavior Therapy for Social Anxiety Disorder

Variations of Cognitive Behavior Therapy for Social Anxiety Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00948974
Enrollment
88
Registered
2009-07-30
Start date
2010-01-31
Completion date
2015-12-31
Last updated
2018-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Anxiety Disorder

Keywords

social anxiety, treatment, Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, Cognitive Therapy

Brief summary

The purpose of this study is to compare the efficacy of two variants of cognitive behavioral therapy (CBT) (cognitive therapy (CT) and acceptance and commitment therapy (ACT)), for the treatment of generalized social anxiety disorder.

Detailed description

We are recruiting a clinical sample of patients who meet diagnostic criteria (per DSM-5) for the generalized subtype of social anxiety disorder. Participants are randomly assigned to the two active intervention conditions; no placebo or sham treatments will be employed. Assessments take place at baseline, pre-treatment, mid-treatment, post-treatment, and at 3- and 12-months follow-up; participants also complete a brief weekly assessment of functioning. Treatment is administered individually by trained graduate students in clinical psychology, directly trained and supervised by the PI and Co-PI. Participants receive 12 weekly 1-hour long sessions. The study design is a 2 (treatment condition) by 5 (assessment occasion) mixed factorial design.

Interventions

BEHAVIORALCognitive Therapy

Cognitive therapy (CT) highlights the identification and reappraisal of distorted or dysfunctional cognitions in the treatment of psychopathology. For example, socially anxious patients are taught to identify the thoughts and underlying beliefs that trigger strong emotional reactions (e.g., if I attempt to initiate a conversation I'll humiliate myself), and then replace these with more accurate, functional thoughts. There is a large body of research supporting the efficacy of CT for mood and anxiety disorders, and for social anxiety disorder in particular (Beck, 2005).

BEHAVIORALAcceptance and Commitment Therapy

ACT does not attempt to modify cognitions directly, but rather seeks to foster a mindful acceptance of whatever thoughts or feelings arise, while still pursuing specific behavioral goals. For example, the individual would be taught simply to notice the thoughts as if from a distance without attempting to modify them, and initiate a conversation. Like other newer mindfulness and acceptance-based models of CBT, ACT also expands the traditional focus on symptom reduction to include an emphasis on broader life goals. The scientific literature on ACT has expanded rapidly over the past ten years. Recent reviews conclude that it appears to be at least as effective as CT, and may work at least in part via distinct treatment mechanisms (Powers, Zum Vörde Sive Vörding, & Emmelkamp, 2009).

Sponsors

Drexel University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinically diagnosable social anxiety disorder (generalized subtype per DSM-IV-TR criteria) * aged 18-65 * working fluency in English * residence in the greater Philadelphia area.

Exclusion criteria

* Pervasive developmental disability * acute suicide potential * inability to travel to the treatment site * schizophrenia or other psychotic disorder * current substance dependence * Comorbid diagnoses of Major Depressive or other mood or anxiety disorders are acceptable ONLY if clearly secondary to the diagnosis of social anxiety disorder.

Design outcomes

Primary

MeasureTime frameDescription
Social Phobia and Anxiety Inventory (SPAI) - Social Phobia Subscalebaseline (pre-treatment; immediately prior to beginning treatment); post-treatment (12 weeks)The SPAI social phobia assess symptoms of social anxiety in the presence of (a) strangers, (b) authority figures, (c) members of the opposite sex, and (d) people in general. The subscale ranges from 32 to 192, where higher scores reflect more severe symptoms of social anxiety.

Secondary

MeasureTime frameDescription
Outcomes Questionnairebaseline (pre-treatment; just before beginning treatment); post-treatment (12 weeks)The Outcomes Questionnaire is a 45-item measure that assesses functioning and is comprised of three subscales: symptom distress, interpersonal relationships, and social role performance, that are combined to create a total score. Scores range from 45 to 180, where higher scores reflect greater levels of dysfunction.
Behavioral Assessment Testbaseline (pre-treatment; just prior to beginning treatment); post-treatment (12 weeks)The assessment consists of two role-played interpersonal interactions and an impromptu speech. The role-plays were video recorded for subsequent rating by two independent assessors. Using a 5-point Likert scale (1 = poor and 5 = excellent), assessors rated global social skills, which were comprised of assessments of verbal content (e.g., amount of speech during task and degree to which speech was relevant and appropriate), nonverbal skills (e.g., degree of fidgeting and eye contact; appropriateness of gestures and posture), and paralinguistic skills (e.g., appropriateness of tone, enunciation, inflection, and rate). Prior research has employed this behavioral assessment protocol (Glassman et al., 2016; Herbert et al., 2005). These results reflect global social skills, which reflect the sum of ratings of verbal, nonverbal, and paralinguistic skills. Scores range from 3 to 15 with higher scores reflecting better social skills.

Countries

United States

Participant flow

Participants by arm

ArmCount
Cognitive Therapy
cognitive therapy and exposure Cognitive Therapy: Cognitive therapy (CT) highlights the identification and reappraisal of distorted or dysfunctional cognitions in the treatment of psychopathology. For example, socially anxious patients are taught to identify the thoughts and underlying beliefs that trigger strong emotional reactions (e.g., if I attempt to initiate a conversation I'll humiliate myself), and then replace these with more accurate, functional thoughts. There is a large body of research supporting the efficacy of CT for mood and anxiety disorders, and for social anxiety disorder in particular (Beck, 2005).
40
Acceptance and Committment Therapy
acceptance and commitment therapy and exposure Acceptance and Commitment Therapy: ACT does not attempt to modify cognitions directly, but rather seeks to foster a mindful acceptance of whatever thoughts or feelings arise, while still pursuing specific behavioral goals. For example, the individual would be taught simply to notice the thoughts as if from a distance without attempting to modify them, and initiate a conversation. Like other newer mindfulness and acceptance-based models of CBT, ACT also expands the traditional focus on symptom reduction to include an emphasis on broader life goals. The scientific literature on ACT has expanded rapidly over the past ten years. Recent reviews conclude that it appears to be at least as effective as CT, and may work at least in part via distinct treatment mechanisms (Powers, Zum Vörde Sive Vörding, & Emmelkamp, 2009).
48
Total88

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up2320

Baseline characteristics

CharacteristicAcceptance and Committment TherapyTotalCognitive Therapy
Age, Continuous29.90 years
STANDARD_DEVIATION 11.66
29.97 years
STANDARD_DEVIATION 10.98
30.05 years
STANDARD_DEVIATION 10.25
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
10 Participants15 Participants5 Participants
Race (NIH/OMB)
Black or African American
8 Participants13 Participants5 Participants
Race (NIH/OMB)
More than one race
9 Participants17 Participants8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
21 Participants43 Participants22 Participants
Sex: Female, Male
Female
27 Participants45 Participants18 Participants
Sex: Female, Male
Male
21 Participants43 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 48
other
Total, other adverse events
0 / 400 / 48
serious
Total, serious adverse events
0 / 400 / 48

Outcome results

Primary

Social Phobia and Anxiety Inventory (SPAI) - Social Phobia Subscale

The SPAI social phobia assess symptoms of social anxiety in the presence of (a) strangers, (b) authority figures, (c) members of the opposite sex, and (d) people in general. The subscale ranges from 32 to 192, where higher scores reflect more severe symptoms of social anxiety.

Time frame: baseline (pre-treatment; immediately prior to beginning treatment); post-treatment (12 weeks)

ArmMeasureGroupValue (MEAN)Dispersion
Cognitive TherapySocial Phobia and Anxiety Inventory (SPAI) - Social Phobia SubscalePre-Treatment131.66 units on a scaleStandard Deviation 19.63
Cognitive TherapySocial Phobia and Anxiety Inventory (SPAI) - Social Phobia SubscalePost-Treatment75.47 units on a scaleStandard Deviation 27.99
Acceptance and Committment TherapySocial Phobia and Anxiety Inventory (SPAI) - Social Phobia SubscalePre-Treatment130.17 units on a scaleStandard Deviation 17.48
Acceptance and Committment TherapySocial Phobia and Anxiety Inventory (SPAI) - Social Phobia SubscalePost-Treatment103.9 units on a scaleStandard Deviation 28.72
Secondary

Behavioral Assessment Test

The assessment consists of two role-played interpersonal interactions and an impromptu speech. The role-plays were video recorded for subsequent rating by two independent assessors. Using a 5-point Likert scale (1 = poor and 5 = excellent), assessors rated global social skills, which were comprised of assessments of verbal content (e.g., amount of speech during task and degree to which speech was relevant and appropriate), nonverbal skills (e.g., degree of fidgeting and eye contact; appropriateness of gestures and posture), and paralinguistic skills (e.g., appropriateness of tone, enunciation, inflection, and rate). Prior research has employed this behavioral assessment protocol (Glassman et al., 2016; Herbert et al., 2005). These results reflect global social skills, which reflect the sum of ratings of verbal, nonverbal, and paralinguistic skills. Scores range from 3 to 15 with higher scores reflecting better social skills.

Time frame: baseline (pre-treatment; just prior to beginning treatment); post-treatment (12 weeks)

Population: A subset of randomized participants (n = 12 for ACT and n = 11 for tCBT) completed this behavioral assessment task.

ArmMeasureGroupValue (MEAN)Dispersion
Cognitive TherapyBehavioral Assessment TestPre-Treatment9.12 units on a scaleStandard Deviation 2.02
Cognitive TherapyBehavioral Assessment TestPost-Treatment10.2 units on a scaleStandard Deviation 2.16
Acceptance and Committment TherapyBehavioral Assessment TestPre-Treatment8.33 units on a scaleStandard Deviation 1.31
Acceptance and Committment TherapyBehavioral Assessment TestPost-Treatment10.64 units on a scaleStandard Deviation 1.37
Secondary

Outcomes Questionnaire

The Outcomes Questionnaire is a 45-item measure that assesses functioning and is comprised of three subscales: symptom distress, interpersonal relationships, and social role performance, that are combined to create a total score. Scores range from 45 to 180, where higher scores reflect greater levels of dysfunction.

Time frame: baseline (pre-treatment; just before beginning treatment); post-treatment (12 weeks)

ArmMeasureGroupValue (MEAN)Dispersion
Cognitive TherapyOutcomes QuestionnairePre-Treatment120.06 units on a scaleStandard Deviation 18.4
Cognitive TherapyOutcomes QuestionnairePost-Treatment91.34 units on a scaleStandard Deviation 24.51
Acceptance and Committment TherapyOutcomes QuestionnairePre-Treatment118.36 units on a scaleStandard Deviation 25.21
Acceptance and Committment TherapyOutcomes QuestionnairePost-Treatment105.54 units on a scaleStandard Deviation 24.39

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026